Longitudinal efficacy of Ertugliflozin in type 2 diabetes: a meta-analysis of randomized controlled trials

CONCLUSION: Ertugliflozin showed clinical efficacy in improving glycemic control, fasting plasma glucose, body weight, and systolic blood pressure in T2DM patients over the studied time intervals compared to placebo.PMID:37955156 | DOI:10.1080/14656566.2023.2279100

Source: Expert Opinion on Pharmacotherapy - November 13, 2023 Category: Drugs & Pharmacology Authors: Parvej Khan Shubhashree Venkatesh Rizwana Parveen Pinki Mishra Seema Jain Nidhi Agarwal Source Type: research